Lisa G Wolf
CIK 1861556 · Chief Financial Officer · last filed 2026-03-19
Lisa G Wolf is a Chief Financial Officer who has filed 14 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for TIVC, was dated Mar 19, 2026. Across all open-market trades the lifetime net is −$83.1K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
14
-$83.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Valion Bio, Inc. (TIVC) Delisted | Chief Financial Officer | 526 | $1.40 | $736 | $0 | 5 | 2026-03-19 |
| Resonant Inc (RESN) Delisted | Chief Accounting Officer | 0 | $4.48 | $0 | -$83.1K | 9 | 2022-03-28 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-19 | Valion Bio, Inc. (TIVC) Delisted | Exer (M) | +92 | $0 | EDGAR |
| 2025-12-22 | Valion Bio, Inc. (TIVC) Delisted | Mixed | +434 | -$565 | EDGAR |
| 2025-08-22 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-08-08 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-20 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-28 | Resonant Inc (RESN) Delisted | Mixed | −170,608 | -$767.7K | EDGAR |
| 2022-01-19 | Resonant Inc (RESN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-03 | Resonant Inc (RESN) Delisted | Mixed | +21,827 | -$32.8K | EDGAR |
| 2021-11-19 | Resonant Inc (RESN) Delisted | Sell (S) | −4,902 | -$11.1K | EDGAR |
| 2021-11-12 | Resonant Inc (RESN) Delisted | Grant (A) | +10,598 | $0 | EDGAR |